Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
REVENUES:
Revenue	$ 129,637	$ 128,356
OPERATING EXPENSES:
General and administrative expense, exclusive of depreciation expense shown below	11,789	16,331
Depreciation	3,715	3,939
Amortization	128	105
Other (income) expense, net	846	(28)
OPERATING INCOME	8,571	6,481
Interest expense	3,423	3,429
Income before income taxes	5,148	3,052
Income tax expense (benefit)	1,658	610
Net income	3,490	2,442
Net income attributable to non-controlling interest	270	69
Net income attributable to Core Laboratories Inc.	$ 3,220	$ 2,373
EARNINGS PER SHARE INFORMATION:
Basic earnings per share	$ 0.07	$ 0.05
Basic earnings per share attributable to Core Laboratories Inc.	0.07	0.05
Diluted earnings per share	0.07	0.05
Diluted earnings per share attributable to Core Laboratories Inc.	$ 0.07	$ 0.05
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	46,859	46,634
Diluted	47,703	47,481
Service [Member]
REVENUES:
Revenue	$ 96,495	$ 91,076
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	73,865	70,934
Product [Member]
REVENUES:
Revenue	33,142	37,280
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	$ 30,723	$ 30,594